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The in vitro gastrointestinal stability of lipid nanocapsules (LNCs) was studied in
different media. The size of LNCs was determined in simulated gastric and
intestinal media. In updated fasted state simulated intestinal fluid (FaSSIF-V2) and
updated fed state simulated intestinal fluid (FeSSIF-V2) media, the encapsulation
ratio of paclitaxel-loaded LNCs was also measured. The size of LNCs was not
modified after 3h in simulated gastric fluid and simulated intestinal fluid described
by the United States Pharmacopeia, in FaSSIF, FaSSIF-V2, and in FeSSIF.
Moreover, in the presence of pancreatin in FeSSIF-V2, a decreased above 30% of
the loading of paclitaxel was observed. This was attributed to the presence of
lipase in pancreatin that could interact with Lipoid (a mixture of
phosphatidylcholine and phosphatidylethanolamine), present on the shell of LNC.
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